PDCD1 and rheumatoid arthritis: Other trials evaluating the use of rosnilimab, another PD-1 agonist antibody [106], in rheumatoid arthritis (RENOIR trial NCT06041269) and ulcerative colitis (ROSETTA trial NCT06127043) are underway or in preparation.